Innovative Technologies Suggest Bright Days and Cooler Nights Can Enhance Sleep for Dementia Patients

New research shows that optimizing indoor temperature and light levels with zero-burden tech can significantly improve sleep quality in people with dementia, offering a promising solution to common sleep disturbances.
Recent research led by the University of Surrey highlights the significant impact of indoor environments on sleep quality in individuals with dementia. By utilizing zero-burden technologies—such as under-the-mattress sensors, contactless bed occupancy monitoring, and environmental sensors—scientists analyzed over 26,000 days and nights of data to understand how light and temperature influence sleep patterns.
The study found that seasonal fluctuations in outdoor temperature and ambient light levels are reflected indoors, affecting sleep timing, duration, and heart rate. Specifically, hotter bedrooms during the night were associated with more disrupted sleep and increased breathing rates in dementia sufferers. Conversely, brighter indoor lighting during the day was linked to longer, more consolidated sleep and healthier breathing patterns.
Dementia-related sleep disturbances—like nighttime restlessness, excessive daytime napping, and circadian rhythm disruptions—adversely affect quality of life and can exacerbate cognitive decline. Adjusting indoor temperatures to cooler levels at night and increasing daylight exposure during the day may mitigate these issues, offering a simple yet effective way to improve well-being.
Professor Anne Skeldon emphasized that by analyzing long-term data in real home environments, this research provides valuable insights into how environmental modifications can reduce sleep disruptions. The non-intrusive sensors employed do not require wearables or recharging, allowing for continuous, long-term monitoring of physiological and environmental factors.
In collaboration with Imperial College London and healthcare partners, the team collected data from 70 individuals with dementia living independently. Findings revealed that many homes experience uniform heat levels year-round, suggesting that seasonal cooling and lighting adjustments could benefit sleep and energy efficiency. Moreover, individual sensitivities vary widely; some are more affected by environmental changes than others.
With climate change increasing the frequency of hot nights, ensuring cooler indoor temperatures and brighter daytime lighting could become essential strategies for enhancing the daily lives of those with dementia. As Professor Dijk noted, digital health technologies hold great potential for ongoing health monitoring, ultimately supporting healthier aging in the community.
For more details, see the full study: Seasonal and daily variation in indoor light and temperature are associated with sleep disturbance in dementia in the journal Sleep.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Common Vitamin D Supplementation May Lower Vitamin D3 Levels
New research suggests that taking vitamin D2 supplements can decrease levels of the more effective vitamin D3, potentially impacting immune and bone health. The study highlights the benefits of opting for vitamin D3 supplements during winter months.
Immune System Responses May Limit the Success of Phage Therapy in Bacterial Infection Treatment
Recent research reveals that immune system responses can unexpectedly hinder the effectiveness of phage therapy against bacterial infections, highlighting the importance of personalized approaches.
Aging Impairs CAR-T Cell Function by Disrupting Cellular Metabolism, New Research Finds
New research reveals that aging hampers CAR-T cell effectiveness by disrupting mitochondrial metabolism, but NAD restoration shows promise for rejuvenating these cells in older cancer patients.
Breakthrough in Gene-Edited Islet Transplant Demonstrates Success in Human Trial
A groundbreaking human trial demonstrates that gene-edited islet cells can survive and function without immune suppression, offering new hope for type 1 diabetes treatment.